{"id":200407,"name":"HERON THERAPEUTICS, INC.","slug":"heron-therapeutics-inc","state":"CA","country":"United States of America","description":"&#226;€‹Pharmaceutical company","totalSpending":1690000,"filings":34,"yearlySpending":[{"year":2018,"income":240000},{"year":2019,"income":200000},{"year":2020,"income":200000},{"year":2021,"income":250000},{"year":2022,"income":200000},{"year":2023,"income":200000},{"year":2024,"income":200000},{"year":2025,"income":200000}],"issues":["PHA","HCR","MMM"],"firms":["FARRAGUT PARTNERS LLP"],"lobbyists":["JEFF MACKINNON","JOSEPH VASAPOLI","JEFFERY MORTIER","JODY GALE","SARAH WALTER","J WALSH","EDWARD WHITFIELD","KRISTEN O'NEILL","WILLIAM KRIEGER","KRISTEN BAUTZ","DYLAN MOORE","CONSTANTINE HINGSON"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Office of Management & Budget (OMB)","White House Office","Food & Drug Administration (FDA)","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["Issues related to opioid epidemic/specifically modifying rate setting for post surgical non opiods.","Issues related to opioids. Medicare coverage decisions.","Medicare coverage decisions.","Issues related to opioids. Medicare coverage decisions.","Medicare coverage decisions."],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}